An integrated proteomics and genomics analysis to unravel a heterogeneous platelet secretion defect

Journal of Proteomics

Volumn 74, Issue 6, 2011, Pages 902-913

  Di Michele, Michela ^a   Thys, Chantal ^a   Waelkens, Etienne ^a   Overbergh, Lut ^a   D'Hertog, Wannes ^a   Mathieu, Chantal ^a   De Vos, Rita ^a   Peerlinck, Kathelijne ^a   Van Geet, Chris ^a   Freson, Kathleen ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

Cytoskeleton; DIGE; Platelets; Proteomics; Secretion defects

Indexed keywords

ADENOSINE DIPHOSPHATE; ADRENALIN; CALCIMYCIN; CD63 ANTIGEN; COLLAGEN; CYTOSKELETON PROTEIN; MESSENGER RNA; PADGEM PROTEIN;

ADULT; ARTICLE; BLEEDING; CLINICAL ARTICLE; CONTROLLED STUDY; ELECTRON MICROSCOPY; FEMALE; GENE; GENOMICS; HUMAN; HUMAN CELL; IMMUNOBLOTTING; MALE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEOMICS; REAL TIME POLYMERASE CHAIN REACTION; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION; THROMBOCYTE DISORDER; THROMBOCYTE RELEASE REACTION;

ADOLESCENT; ADULT; BLOOD PLATELETS; CALCIMYCIN; CHILD; CYTOPLASMIC GRANULES; CYTOSKELETAL PROTEINS; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; FEMALE; GENOMICS; HUMANS; MALE; MIDDLE AGED; PLATELET AGGREGATION; PLATELET STORAGE POOL DEFICIENCY; PROTEOMICS; RNA, MESSENGER;

EID: 79955463624     PISSN: 18743919     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jprot.2011.03.007     Document Type: Article

References (48)

1. Peyvandi F., Cattaneo M., Inbal A., De Moerloose P., Spreafico M. Rare bleeding disorders. Haemophilia 2008, 3:202-210.
2. Weiss H.J. Congenital disorders of platelet function. Semin Hematol 1980, 17:228-241.
3. Cattaneo M. Congenital disorders of platelet secretion. Platelets in thrombotic and non-thrombotic disorders: pathophysiology, pharmacology and therapeutics 2002, 655-673. Cambridge University Press, Cambridge. P. Gresele, C. Page, V. Fuster, J. Vermeylen (Eds.).
4. Weiss H.J., Witte L.D., Kaplan K.L., Lages B.A., Chernoff A., Nossel H.L., et al. Heterogeneity in storage pool deficiency: studies on granule-bound substances in 18 patients including variants deficient in alpha-granules, platelet factor 4, beta-thromboglobulin, and platelet-derived growth factor. Blood 1979, 54:1296-1319.
5. Coppinger J.A., Cagney G., Toomey S., Kislinger T., Belton O., McRedmond J.P., et al. Characterization of the proteins released from activated platelets leads to localization of novel platelet proteins in human atherosclerotic lesions. Blood 2004, 103(6):2096-2104.
6. Marcus K., Immler D., Sternberger J., Mryer H.E. Identification of platelet proteins separated by two-dimensional gel electrophoresis and analyzed by matrix assisted laser desorption/ionization-time of flight-mass spectrometry and detection of tyrosine-phosphorylated proteins. Electrophoresis 2000, 21(13):2622-2636.
7. García A., Prabhakar S., Brock C.J., Pearce A.C., Dwek R.A., Watson S.P., et al. Extensive analysis of the human platelet proteome by two-dimensional gel electrophoresis and mass spectrometry. Proteomics 2004, 4:656-668.
8. Martens L., Van Damme P., Van Damme J., Staes A., Timmerman E., Ghesquière B., et al. The human platelet proteome mapped by peptide-centric proteomics: a functional protein profile. Proteomics 2005, 5(12):3193-3204.
9. Della Corte A., Maugeri N., Pampuch A., Cerletti C., de Gaetano G., Rotilio D. Application of 2-dimensional difference gel electrophoresis (2D-DIGE) to the study of thrombin-activated human platelet secretome. Platelets 2008, 19(1):43-50.
10. Zahedi R.P., Lewandrowski U., Wiesner J., Wortelkamp S., Moebius J., Schütz C., et al. Phosphoproteome of resting human platelets. J Proteome Res 2008, 7(2):526-534.
11. Piersma S.R., Broxterman H.J., Kapci M., de Haas R.R., Hoekman K., Verheul H.M., et al. Proteomics of the TRAP-induced platelet releasate. J Proteomics 2009, 72(1):91-109.
12. Senis Y.A., Antrobus R., Severin S., Parguiña A.F., Rosa I., Zitzmann N., et al. Proteomic analysis of integrin alphaIIbbeta3 outside-in signaling reveals Src-kinase-independent phosphorylation of Dok-1 and Dok-3 leading to SHIP-1 interactions. J Thromb Haemost 2009, 7(10):1718-1726.
13. Qureshi A.H., Chaoji V., Maiguel D., Aridi MH F., Barth C.J., Salem S.M., et al. Proteomic and phospho-proteomic profile of human platelets in basal, resting state: insights into integrin signaling. PLoS ONE 2009, 4(10):e7627.
14. Yu Y., Leng T., Yun D., Liu N., Yao J., Dai Y., et al. Global analysis of the rat and human platelet proteome-the molecular blueprint for illustrating multi-functional platelets and cross-species function evolution. Proteomics 2010, 10(13):2444-2457.
15. Maynard D.M., Heijnen H.F., Horne M.K., White J.G., Gahl W.A. Proteomic analysis of platelet alpha-granules using mass spectrometry. J Thromb Haemost 2007, 5(9):1945-1955.
16. Hernandez-Ruiz L., Valverde F., Jimenez-Nuñez M.D., Ocaña E., Sáez-Benito A., Rodríguez-Martorell J., et al. Organellar proteomics of human platelet dense granules reveals that 14-3-3zeta is a granule protein related to atherosclerosis. J Proteome Res 2007, 6(11):4449-4457.
17. Garcia B.A., Smalley D.M., Cho H., Shabanowitz J., Ley K., Hunt D.F. The platelet microparticle proteome. J Proteome Res 2005, 4:1516-1521.
18. Moebius J., Zahedi R.P., Lewandrowski U., Berger C., Walter U., Sickmann A. The human platelet membrane proteome reveals several new potential membrane proteins. Mol Cell Proteomics 2005, 4:1754-1761.
19. Maurer-Spurej E., Kahr W.H., Carter C.J., Pittendreigh C., Cameron M., Cyr T.D. The value of proteomics for the diagnosis of a platelet-related bleeding disorder. Platelets 2008, 19(5):342-351.
20. Sacristan D., Marques M., Zamorano J., Armengol J., Del Castillo J., Martín J., et al. Modifications by Olmesartan medoxomil treatment of the platelet protein profile of moderate hypertensive patients. Proteomics Clin Appl 2008, 2:1300-1312.
21. Springer D.L., Miller J.H., Spinelli S.L., Pasa-Tolic L., Purvine S.O., Daly D.S., et al. Platelet proteome changes associated with diabetes and during platelet storage for transfusion. J Proteome Res 2009, 8(5):2261-2272.
22. Marques M., Sacristán D., Mateos-Cáceres P.J., Herrero J., Arribas M.J., González-Armengol J.J., et al. Different protein expression in normal and dysfunctional platelets from uremic patients. J Nephrol 2010, 23(1):90-101.
23. Maynard D.M., Heijnen H.F., Gahl W.A., Gunay-Aygun M. The alpha granule proteome: novel proteins in normal and ghost granules in gray platelet syndrome. J Thromb Haemost 2010, 8:1786-1795.
24. Freson K., De Vos R., Wittevrongel C., Thys C., Defoor J., Vanhees L., et al. The TUBB1 Q43P functional polymorphism reduces the risk of cardiovascular disease in men by modulating platelet function and structure. Blood 2005, 106(7):2356-2362.
25. Oury C., Toth-Zsamboki E., Thys C., Tytgat J., Vermylen J., Hoylaerts M.F. The ATP-gated P2X1 ion channel acts as a positive regulator of platelet responses to collagen. Thromb Haemost 2001, 86(5):1264-1271.
26. Di Michele M., Della Corte A., Cicchillitti L., Del Boccio P., Urbani A., Ferlini C. A proteomic approach to paclitaxel chemoresistance in ovarian cancer cell lines. Biochim Biophys Acta 2009, 1794(2):225-236.
27. Shevchenko A., Wilm M., Vorm O., Mann M. Mass spectrometric sequencing of proteins from silver stained polyacrylamide gels. Anal Chem 1996, 68(5):850-858.
28. Gharahdaghi F., Weinberg C.R., Meagher D.A., Imai B.S., Mische S.M. Mass spectrometric identification of proteins from silver-stained polyacrylamide gel: a method for the removal of silver ions to enhance sensitivity. Electrophoresis 1999, 20(3):601-605.
29. Nishibori M., Cham B., McNicol A., Shalev A., Jain N., Gerrard J.M. The protein CD63 is in platelet dense granules, is deficient in a patient with Hermansky-Pudlak syndrome, and appears identical to granulophysin. J Clin Invest 1993, 91(4):1775-1782.
30. Prabakaran S., Swatton J.E., Ryan M.M., Huffaker S.J., Huang J.T., Griffin J.L., et al. Mitochondrial dysfunction in schizophrenia: evidence for compromised brain metabolism and oxidative stress. Mol Psychiatry 2004, 9(7):684-697.
31. Karp N.A., Spencer M., Lindsay H., O'Dell K., Lilley K.S. Impact of replicate types on proteomic expression analysis. J Proteome Res 2005, 4(5):1867-1871.
32. Karp N.A., Lilley K.S. Investigating sample pooling strategies for DIGE experiments to address biological variability. Proteomics 2009, 9:388-397.
33. Ioannidis J.P., Trikalinos T.A., Khoury M.J. Implications of small effect sizes of individual genetic variants on the design and interpretation of genetic association studies of complex diseases. Am J Epidemiol 2006, 164:609-614.
34. Emanuelsson O., Brunak S., von Heijne G., Nielsen H. Locating proteins in the cell using TargetP, SignalP, and related tools. Nat Protoc 2007, 2:953-971.
35. Schulz C., Leuschen N.V., Fröhlich T., Lorenz M., Pfeiler S., Gleissner C.A., et al. Identification of novel downstream targets of platelet glycoprotein VI activation by differential proteome analysis: implications for thrombus formation. Blood 2010, 115(20):4102-4110.
36. Thiele T., Steil L., Gebhard S., Scharf C., Hammer E., Brigulla M., et al. Profiling of alterations in platelet proteins during storage of platelet concentrates. Transfusion 2007, 47(7):1221-1233.
37. Nieswandt B., Moser M., Pleines I., Varga-Szabo D., Monkley S., Critchley D., et al. Loss of talin1 in platelets abrogates integrin activation, platelet aggregation, and thrombus formation in vitro and in vivo. J Exp Med 2007, 204:3113-3118.
38. Petrich B.G., Marchese P., Ruggeri Z.M., Spiess S., Weichert R.A., Ye F., et al. Talin is required for integrin-mediated platelet function in hemostasis and thrombosis. J Exp Med 2007, 204:3103-3111.
39. Smalley D.M., Root K.E., Cho H., Ross M.M., Ley K. Proteomic discovery of 21 proteins expressed in human plasma-derived but not platelet-derived microparticles. Thromb Haemost 2007, 97:67-80.
40. Franke A., Balschun T., Karlsen T.H., Sventoraityte J., Nikolaus S., Mayr G., et al. Sequence variants in IL10, ARPC2 and multiple other loci contribute to ulcerative colitis susceptibility. Nat Genet 2008, 40(11):1319-1323.
41. Lelias J.M., Adra C.N., Wulf G.M., Guillemot J.C., Khagad M., Caput D., et al. cDNA cloning of a human mRNA preferentially expressed in hematopoietic cells and with homology to a GDP-dissociation inhibitor for the rho GTP-binding proteins. PNAS 1993, 90(4):1479-1483.
42. Leffers H., Nielsen M.S., Andersen A.H., Honoré B., Madsen P., Vandekerckhove J., et al. Identification of two human Rho GDP dissociation inhibitor proteins whose overexpression leads to disruption of the actin cytoskeleton. Exp Cell Res 1993, 209(2):165-174.
43. Flaumenhaft R., Dilks J.R., Rozenvayn N., Monahan-Earley R.A., Feng D., Dvorak A.M. The actin cytoskeleton differentially regulates platelet alpha-granule and dense-granule secretion. Blood 2005, 105(10):3879-3887.
44. Pleines I., Eckly A., Elvers M., Hagedorn I., Eliautou S., Bender M., et al. Multiple alterations of platelet functions dominated by increased secretion in mice lacking Cdc42 in platelets. Blood 2010, 115(16):3364-3373.
45. Lyubchenko T.A., Wurth G.A., Zweifach A. The actin cytoskeleton and cytotoxic T lymphocytes: evidence for multiple roles that could affect granule exocytosis-dependent target cell killing. J Physiol 2003, 547:835-847.
46. Gibbs D., Azarian S.M., Lillo C., Kitamoto J., Klomp A.E., Steel K.P., et al. Role of myosin VIIa and Rab27a in the motility and localization of RPE melanosomes. J Cell Sci 2004, 117:6473-6483.
47. Lian L., Wang Y., Flick M., Choi J., Scott E.W., Degen J., et al. Loss of pleckstrin defines a novel pathway for PKC-mediated exocytosis. Blood 2009, 113:3577-3584.
48. Baig A., Bao X., Haslam R.J. Proteomic identification of pleckstrin-associated proteins in platelets: possible interactions with actin. Proteomics 2009, 9(17):4254-4258.